Hierarchical Analytics Framework for Cardiovascular Disease Phenotyping
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical imaging techniques face challenges in effectively integrating high-resolution data into clinical workflows, leading to information overload for clinicians and inefficient use of imaging modalities, particularly in characterizing cardiovascular diseases and predicting adverse events, where non-invasive methods for assessing flow reserve and plaque stability are limited by invasive procedures and high costs.
Innovation Solution
A hierarchical analytics framework that combines computerized image analysis and data fusion algorithms with clinical chemistry and blood biomarker data to provide a multi-factorial panel for distinguishing between disease subtypes, using convolutional neural networks for phenotyping and risk stratification, and enriching datasets with semantic segmentation and spatial transformations to enhance accuracy and reduce noise.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If high-resolution imaging data is collected to improve disease characterization accuracy, then measurement precision is improved, but information overload and device complexity increase
Solution Approach 1:
The system extracts only the most clinically relevant features from high-resolution imaging data using automated analysis algorithms. Convolutional neural networks and random forest classifiers identify and extract key phenotypic characteristics (plaque morphology, flow reserve metrics, tissue characteristics) while filtering out redundant information, thus maintaining measurement precision while reducing information overload for clinicians.
Solution Approach 2:
The system transforms complex imaging data into simplified quantitative parameters and risk scores. By converting high-dimensional imaging data into standardized phenotypic classifications and adverse event risk stratifications, the system preserves diagnostic accuracy while presenting information in a clinically manageable format that integrates efficiently into existing workflows.
2Measurement precision
If invasive procedures are used to assess flow reserve and plaque stability, then measurement precision is improved, but patient harm and cost increase
Solution Approach 1:
The system uses non-invasive imaging modalities (CT, MRI, ultrasound) as intermediaries to assess flow reserve and plaque stability without direct physical intrusion into the vascular system. These imaging techniques provide surrogate measurements that correlate with invasive gold standards while eliminating procedural risks, patient discomfort, and associated costs.
Solution Approach 2:
The system replaces mechanical invasive measurement devices (pressure wires, catheters) with non-invasive imaging-based computational methods. By using image processing algorithms and machine learning models to analyze anatomical and functional imaging data, the system achieves comparable measurement precision without the harmful effects of invasive procedures.
3Reliability
If quantitative imaging analysis is implemented to improve disease prediction, then reliability is improved, but device complexity and processing time increase
Solution Approach 1:
The system performs automated quantitative analysis and phenotyping during the imaging acquisition process itself. By pre-processing and analyzing imaging data in real-time or near-real-time using embedded algorithms, the system generates diagnostic results and risk stratifications without requiring separate manual analysis steps, thus improving reliability while maintaining clinical workflow efficiency.
Solution Approach 2:
The system provides automated feedback in the form of phenotypic classifications and risk predictions directly to clinicians. By integrating quantitative imaging results into the clinical decision-making process through standardized reports and visualizations, the system improves prediction reliability while reducing the time clinicians spend on manual data interpretation.
Data Source
AI summary
Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.